Microbiology

  1. Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2

    1. Mark Dittmar
    2. Jae Seung Lee
    3. Kanupriya Whig
    4. Elisha Segrist
    5. Minghua Li
    6. Kellie Jurado
    7. Kirandeep Samby
    8. Holly Ramage
    9. David Schultz
    10. Sara Cherry

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies

    1. Aurelie Velay
    2. Floriane Gallais
    3. Ilies Benotmane
    4. Marie Josée Wendling
    5. François Danion
    6. Olivier Collange
    7. Jérôme De Sèze
    8. Catherine Schmidt-Mutter
    9. Francis Schneider
    10. Pascal Bilbault
    11. Ferhat Meziani
    12. Samira Fafi-Kremer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Variant analysis of SARS-CoV-2 strains in Middle Eastern countries

    1. Khalid Mubarak Bindayna
    2. Shane Crinion

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Bcr-Abl tyrosine kinase inhibitor imatinib as a potential drug for COVID-19

    1. Nirmitee Mulgaonkar
    2. Haoqi Wang
    3. Samavath Mallawarachchi
    4. Sandun Fernando
    5. Byron Martina
    6. Daniel Ruzek

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Polymorphism and Selection Pressure of SARS-CoV-2 Vaccine and Diagnostic Antigens: Implications for Immune Evasion and Serologic Diagnostic Performance

    1. Eric Dumonteil
    2. Claudia Herrera

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike

    1. Lihong Liu
    2. Pengfei Wang
    3. Manoj S. Nair
    4. Jian Yu
    5. Micah Rapp
    6. Qian Wang
    7. Yang Luo
    8. Jasper F-W. Chan
    9. Vincent Sahi
    10. Amir Figueroa
    11. Xinzheng V. Guo
    12. Gabriele Cerutti
    13. Jude Bimela
    14. Jason Gorman
    15. Tongqing Zhou
    16. Zhiwei Chen
    17. Kwok-Yung Yuen
    18. Peter D. Kwong
    19. Joseph G. Sodroski
    20. Michael T. Yin
    21. Zizhang Sheng
    22. Yaoxing Huang
    23. Lawrence Shapiro
    24. David D. Ho

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Holder Pasteurization Inactivates SARS-CoV-2 in Human Breast Milk

    1. Carina Conzelmann
    2. Rüdiger Groß
    3. Toni Luise Meister
    4. Daniel Todt
    5. Adalbert Krawczyk
    6. Ulf Dittmer
    7. Steffen Stenger
    8. Jan Münch
    9. Eike Steinmann
    10. Janis A Müller
    11. Stephanie Pfaender

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Oral drug repositioning candidates and synergistic remdesivir combinations for the prophylaxis and treatment of COVID-19

    1. Malina A. Bakowski
    2. Nathan Beutler
    3. Emily Chen
    4. Tu-Trinh H. Nguyen
    5. Melanie G. Kirkpatrick
    6. Mara Parren
    7. Linlin Yang
    8. James Ricketts
    9. Anil K. Gupta
    10. Mitchell V. Hull
    11. Peter G. Schultz
    12. Dennis R. Burton
    13. Arnab K. Chatterjee
    14. Case W. McNamara
    15. Thomas F. Rogers

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry

    1. David L. Suarez
    2. Mary J. Pantin-Jackwood
    3. David E. Swayne
    4. Scott A. Lee
    5. Suzanne M. DeBlois
    6. Erica Spackman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection

    1. Brandon Beddingfield
    2. Naoki Iwanaga
    3. Prem Chapagain
    4. Wenshu Zheng
    5. Chad J. Roy
    6. Tony Y. Hu
    7. Jay Kolls
    8. Gregory Bix

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 55 of 251 Next